ADNT vs TSLA

The Advanced Deterministic Scorecard reveals critical weaknesses in Adient plc's financial health, with a Piotroski F-Score of just 2/9 indicating severe operational and profitability concerns. Despite a low forward P/E of 7.11 and a price/book below 1, suggesting potential value, the company is unprofitable (negative net margin and ROE), highly leveraged (Debt/Equity of 1.23), and experiencing sharply declining earnings (YoY EPS down 23.5%, earnings growth -76.6%). Insider selling, inconsistent earnings beats (only 1 of last 4 quarters), and weak long-term price performance (-47.7% over 3 years) further undermine confidence. While analysts recommend a 'buy' with a $25.05 target, the fundamental fragility outweighs near-term optimism.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.